Clinical Trial Update: Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating pembrolizumab plus brentuximab vedotin versus GDP chemotherapy with stem cell transplant for relapsed/refractory Hodgkin lym…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Brentuximab vedotin (Adcetris) (brentuximab vedotin)
• Pembrolizumab (Keytruda) (pembrolizumab)

Snippet

Sponsor: Canadian Cancer Trials Group | Conditions: Hodgkin Lymphoma | Phase 2 | Status: RECRUITING